Related Experiment Video
Updated: Jun 23, 2026
07:35
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
Published on: October 11, 2018
Clinical trial designs for predictive biomarker validation: one size does not fit all
Sumithra J Mandrekar1, Daniel J Sargent
1Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota 55905, USA. mandrekar.sumithra@mayo.edu
Journal of Biopharmaceutical Statistics
|April 23, 2009
Summary
This study evaluates clinical trial designs for validating predictive biomarkers in cancer. It compares targeted versus unselected designs and assesses the efficiency of unselected designs for personalized medicine.
Area of Science:
- Oncology
- Biomarker Discovery
- Clinical Trial Design
Background:
- Traditional cancer staging systems lack precision for targeted therapies.
- Biomarkers offer potential for personalized medicine by integrating tumor genetics and patient genotype.
- Biomarkers aid in patient stratification, treatment response prediction, and differential diagnosis.
Purpose of the Study:
- To explore clinical trial designs for predictive biomarker validation.
- To compare enrichment (targeted) versus unselected trial designs.
- To evaluate the efficiency of unselected designs for biomarker validation.
Main Methods:
- Case studies comparing enrichment and unselected designs based on clinical questions, evidence strength, and assay reproducibility.
- Evaluation of the efficiency (events and sample size) of two unselected designs.
- Analysis of biomarker prevalence and hazard ratios impact on efficiency.
Main Results:
- Discussion on the appropriateness of enrichment versus unselected designs for specific clinical scenarios.
- Evaluation of the efficiency of unselected designs under various prevalence and hazard ratio conditions.
- Identification of key factors influencing the choice and efficiency of trial designs.
Conclusions:
- The methodology for clinical validation of biomarker-guided therapy is crucial for advancing personalized medicine.
- Informed selection between enrichment and unselected designs optimizes biomarker validation.
- Efficient trial designs are essential for the successful implementation of biomarker-guided cancer therapies.
Related Concept Videos
01:15Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
01:20Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs
Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to subjects...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:11Bioavailability Study Design: Single Versus Multiple Dose Studies
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...